APA

de Jong J., Hellemans P., De Wilde S., Patricia D., Masterson T., Manikhas G., Myasnikov A., Osmanov D., Córdoba R., Panizo C., de Zwart L., Snoeys J., Chauhan V., Jiao J., Sukbuntherng J. & Ouellet D. (20190624). A drug-drug interaction study of ibrutinib with moderate/strong CYP3A inhibitors in patients with B-cell malignancies. : Leukemia & lymphoma.

Chicago

de Jong Jan, Hellemans Peter, De Wilde Severijn, Patricia Daniel, Masterson Tara, Manikhas Georgii, Myasnikov Alexander, Osmanov Dzhelil, Córdoba Raúl, Panizo Carlos, de Zwart Loeckie, Snoeys Jan, Chauhan Vijay, Jiao James, Sukbuntherng Juthamas and Ouellet Daniele. 20190624. A drug-drug interaction study of ibrutinib with moderate/strong CYP3A inhibitors in patients with B-cell malignancies. : Leukemia & lymphoma.

Harvard

de Jong J., Hellemans P., De Wilde S., Patricia D., Masterson T., Manikhas G., Myasnikov A., Osmanov D., Córdoba R., Panizo C., de Zwart L., Snoeys J., Chauhan V., Jiao J., Sukbuntherng J. and Ouellet D. (20190624). A drug-drug interaction study of ibrutinib with moderate/strong CYP3A inhibitors in patients with B-cell malignancies. : Leukemia & lymphoma.

MLA

de Jong Jan, Hellemans Peter, De Wilde Severijn, Patricia Daniel, Masterson Tara, Manikhas Georgii, Myasnikov Alexander, Osmanov Dzhelil, Córdoba Raúl, Panizo Carlos, de Zwart Loeckie, Snoeys Jan, Chauhan Vijay, Jiao James, Sukbuntherng Juthamas and Ouellet Daniele. A drug-drug interaction study of ibrutinib with moderate/strong CYP3A inhibitors in patients with B-cell malignancies. : Leukemia & lymphoma. 20190624.